References
- ShawJESicreeRAZimmetPZGlobal estimates of the prevalence of diabetes for 2010 and 2030Diabetes Res Clin Pract20108741419896746
- AielloLMPerspectives on diabetic retinopathyAm J Ophthalmol200313612213512834680
- CiullaTAAmadorAGZinmanBDiabetic retinopathy and diabetic macular edema: pathophysiology, screening, and novel therapiesDiabetes Care2003262653266412941734
- BrownleeMThe pathobiology of diabetic complications: A unifying mechanismDiabetes2005541615162515919781
- PoberJSSessaWCEvolving functions of endothelial cells in inflammationNat Rev Immunol2007780381517893694
- SangDND’AmorePAIs blockade of vascular endothelial growth factor beneficial for all types of diabetic retinopathy?Diabetologia2008511570157318607560
- MignattiPRifkinDBPlasminogen activators and matrix metalloproteinases in angiogenesisEnzyme Protein1996491171378797002
- CastellinoFJPloplisVAStructure and function of the plasminogen/plasmin systemThromb Haemost20059364765415841308
- AdibhatlaRMHatcherJFTissue plasminogen activator (tPA) and matrix metalloproteinases in the pathogenesis of stroke: therapeutic strategiesCNS Neurol Disord Drug Targets2008724325318673209
- Lopez-LopezFRodriguez-BlancoMGómez-UllaFMarticorenaJEnzymatic vitreolysisCurr Diabetes Rev20095576219199900
- El-AsrarAMAl-MezainHSPharmacologic vitreolysis in diabetic retinopathyCurr Pharm Biotechnol20111240640920939804
- Díaz-LlopisMUdaondoPArevaloFIntravitreal plasmin without associated vitrectomy as a treatment for refractory diabetic macular edemaJ Ocul Pharmacol Ther20092537938419650710
- RizzoSPellegriniGBenocciFBeltingCBaicchiMVispiMAutologous plasmin for pharmacologic vitreolysis prepared 1 hour before surgeryRetina20062679279616963853
- SenturkFOzdemirHKaracorluMKaracorluSAUysalOMicroperimetric changes after intravitreal triamcinolone acetonide injection for macular edema due to central retinal vein occlusionRetina2010301254126120827142
- Khurieva-SattlerEKrauseMLöwUComparison of pars plana vitrectomy with ILM peeling and intravitreal triamcinolone in diffuse diabetic macular edemaKlin Monbl Augenheilkd201022749650020221984
- Díaz-LlopisMUdaondoPGarcía-DelpechSCerveraESalomDQuijadaAEnzymatic vitrectomy by intravitreal autologous plasmin injection, as initial treatment for diffuse diabetic macular edemaArch Soc Esp Oftalmol200883778418260017
- SakumaTMizotaAInoueJTanakaMIntravitreal injection of autologous plasmin enzyme for macular edema associated with branch retinal vein occlusionAm J Ophthalmol201015087688220801424
- UdaondoPDíaz-LlopisMGarcía-DelpechSSalomDRomeroFJIntravitreal plasmin without vitrectomy for macular edema secondary to branch retinal vein occlusionArch Ophthalmol201112928328721402982
- WilsonCABerkowitzBASatoYAndoNHandaJTde JuanEJrTreatment with intravitreal steroid reduced blood-retinal barrier breakdown due to retinal photocoagulationArch Ophthamol1992110811551159
- RangasamySMcGuirePGDasADiabetic retinopathy and inflammation: novel therapeutic targetsMiddle East Afr J Ophthalmol201219525922346115
- BoyerDSFaberDGuptaSOzurdex CHAMPLAIN Study GroupDexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patientsRetina20113191592321487341
- ElbendaryAMShahinMMIntravitreal diclofenac versus intravitreal triamcinolone acetonide in the treatment of diabetic macular edemaRetina2011312058206421765371
- GandorferAObjective of pharmacologic vitreolysisDev Ophthalmol2009441619494646
- KramarMVuLWhitsonJTHeYGThe effect of intravitreal triamcinolone on intraocular pressureCurr Med Res Opin2007231253125817559723
- García FernándezMGarcía AlonsoAFonollá GilMRodríguez VillaSIntravitreal triamcinolone acetonide use in diffuse persistent diabetic macular edemaArch Soc Esp Oftalmol20118631431922004576
- BozkurtEKaraNYaziciATProphylactic selective laser trabeculoplasty in the prevention of intraocular pressure elevation after intravitreal triamcinolone acetonide injectionAm J Ophthalmol201115297698121861972